Ethan Dmitrovsky, MD, Oral History Interview, March 3, 2015
Files
Download Full Interview Transcript (519 KB)
Loading...
Description
Major Topics Covered:
- Personal and educational background; overseas experience and inspiration
- Research: cell differentiation; retinoids in leukemic differentiation; lung cancer studies
- The Role of the Provost; personal goals; institutional mandate; detailed of plans
- MD Anderson’s ten-year strategic plan
- Research in an environment of changing economics and health care delivery
Interview Chapters
Chapter 01: An Early Desire to Be a Physician and Focus on Difficult Illnesses
Chapter 02: College Influences: A Research Project, a Book, and Working as an Orderly
Chapter 04: A Fellowship and a Risky and Successful Study of Cell Differentiation
Chapter 06: Shifting Focus to Lung Cancer
Chapter 07: Coming to MD Anderson to Have a Broader Impact on Health
Chapter 08: Views on MD Anderson's 10-Year Strategic Plan and the Role of the Provost
Identifier
DmitrovskyE_01_20150303
Publication Date
3-5-2015
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center; UT MD Anderson Cancer Center; University of Texas System. M.D. Anderson Cancer Center; M.D. Anderson Hospital and Tumor Institute at Houston; University of Texas M.D. Anderson Cancer Center; M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Dmitrovsky, Ethan MD and Rosolowski, Tacey A. PhD, "Ethan Dmitrovsky, MD, Oral History Interview, March 3, 2015" (2015). Interview Sessions. 102.
https://openworks.mdanderson.org/mchv_interviewsessions/102
Conditions Governing Access
Open
About the Interview
About the Interview Subject:
Ethan Dmitrovsky, MD came to MD Anderson in 2013 to serve as the institution’s Provost and Executive Vice President. He has a faculty appointment in the Department of Thoracic/Head and Neck Medical Oncology in the Division of Cancer Medicine.
Dr. Dmitrovsky’s translational research areas include: retinoid differentiation-based therapy for acute promyelocytic leukemia (APL); developed the molecular genetic test used to detect the PML/RARalpha transcript from the APL t(15;17) rearrangement; retinoid mechanisms leading to cell cycle arrest and repair of DNA damage in normal/malignant lung epithelial cells; engineered transgenic mouse models that express wild-type or proteasomal degradation-resistant cyclin E species in the lung; derived lung cancer cell lines leading to a new model to assess activity of lung cancer therapy and chemopreventive agents (antineoplastics).